SHIN; Dongok
Patent Applications and Registrations
Patent applications and USPTO patent grants for SHIN; Dongok.The latest application filed is for "antibody binding to fcrn for treating autoimmune diseases".
- SHIN; Dongok - Gyeonggi-do KR
| Patent | Date |
|---|---|
| Antibody Binding To Fcrn For Treating Autoimmune Diseases App 20200109201 - KIM; Sung Wuk ; et al. | 2020-04-09 |
| Antibody binding to FcRn for treating autoimmune diseases Grant 10,544,226 - Kim , et al. Ja | 2020-01-28 |
| Antibody binding to FcRn for treating autoimmune diseases Grant 10,336,825 - Kim , et al. | 2019-07-02 |
| Antibody Binding To Fcrn For Treating Autoimmune Diseases App 20190135917 - KIM; Sung Wuk ; et al. | 2019-05-09 |
| FcRn-specific human antibody and composition for treatment of autoimmune diseases Grant 10,280,207 - Kim , et al. | 2019-05-07 |
| Antibody Binding To Fcrn For Treating Autoimmune Diseases App 20170210801 - Kim; Sung Wuk ; et al. | 2017-07-27 |
| Antibody Binding To Fcrn For Treating Autoimmune Diseases App 20170210805 - Kim; Sung Wuk ; et al. | 2017-07-27 |
| Fcrn-specific Human Antibody And Composition For Treatment Of Autoimmune Diseases App 20160137713 - Kim; Sung Wuk ; et al. | 2016-05-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 